H. Hamidian et al. / Bioorg. Med. Chem. xxx (2013) xxx–xxx
5
252(9), 480(M+, 3). Anal. Calcd for C25H19N4O3F3: C, 62.50; H, 3.96;
N, 11.67. Found: C, 62.67; H, 4.11; N, 11.51.
acid and L-mimosine was used as reference standard inhibitors for
comparison.
3.6.3. 2-[2-(4-{4-[1-(4-Fluorophenyl)methylidene]-5-oxo-4,5-
dihydro-1,3-oxazol-2-yl}phenyl)-1-diazenyl]-1-naphthyl
acetate (4c)
3.7.2. Inhibition of melanin production
Melanin production inhibition was ascertained by method of
Wang et al.24 A total of 8 ꢁ 104 cells were added to 60 mm plates,
Brown powder; mp: 246–248 °C. IR (KBr)
v
: 1800, 1726,
and were incubated at 37 °C in a CO2 incubator then 10 ll test
1654 cmꢀ1 1H NMR (DMSO-d6, 400 MHz) d: 2.53 (s, 3H), 7.19–
.
samples in DMSO were added to plates and were incubated for
9.04 (m, 15H). MS (EI) m/z (%): 42(100), 76(11), 91(9), 104(10),
143(51), 171(5), 247(3), 275(7). Anal. Calcd for C28H18N3O4F: C,
70.15; H, 3.76; N, 8.77. Found: C, 70.23; H, 3.59; N, 9.02.
72 h at 37 °C in a CO2 incubator. After washing with PBS, cells were
destroyed with 1 ml of 1 N NaOH, and 200 ll portions of raw cell
extracts were moved to 96-well plates. Melanin production inhibi-
tion was determined by recording absorbance at 475 nm. The ef-
fects of test samples on melanin contents are stated as percent
inhibitions of the value obtained in B16F10 mouse melanoma cells
which were cultured with DMSO alone.
3.6.4. 2-{2-[4-(5-Oxo-4-{1-[4-
(trifluoromethoxy)phenyl]methylidene}-4,5-dihydro-1,3-
oxazol-2-yl)phenyl]-1-diazenyl}-1-naphthyl acetate (4d)
Red powder; mp: 214–216 °C. IR (KBr)
v: 1796, 1762,
1656 cmꢀ1 1H NMR (DMSO-d6, 400 MHz) d: 2.53 (s, 3H), 7.19–
.
3.7.3. Cytotoxicity assay
9.03 (m, 15H). MS (EI) m/z (%): 42(100), 91(75), 143(59), 171(11),
247(4), 275(17). Anal. Calcd for C29H18N3O5F3: C, 63.85; H, 3.30;
N, 12.07. Found: C, 63.92; H, 3.13; N, 12.33.
Cytotoxicity assays were performed using a micro-culture MTT
method described by Han et al.25 A B16F10 mouse melanoma cell
suspensionwas poured into a 96-well plate (103 cells/well) and
cells were allowed to completely stick to each other overnight. Test
samples were then added to the plate and were incubated at 37 °C
3.6.5. 1-[2-(4-{4-[1-(4-Fluorophenyl)methylidene]-5-oxo-4,5-
dihydro-1,3-oxazol-2-yl}phenyl)-1-diazenyl]-2-naphthyl
acetate (4e)
for 72 h in a CO2 incubator. 20
then added per well and incubated for 4 h. Supernatant was then
removed and formazan was solubilized by adding 150 l DMSO
ll of MTT solution (2 mg/ml) was
Dark red powder; mp: 280–282 °C. IR (KBr)
v
: 1790, 1763,
l
1652 cmꢀ1 1H NMR (DMSO-d6, 400 MHz) d: 2.37 (s, 3H), 7.19–
.
to each well with mild shaking. Absorbance at 490 nm was re-
8.76 (m, 15H). MS (EI) m/z (%): 42(100), 91(14), 104(4), 120(8),
143(44), 171(9), 274(7), 275(9). Anal. Calcd for C28H18N3O4F: C,
70.15; H, 3.76; N, 8.77. Found: C, 69.98; H, 3.96; N, 8.88.
corded using an ELISA plate reader.
Acknowledgment
3.6.6. 1-{2-[4-(5-Oxo-4-{1-[4-
(trifluoromethoxy)phenyl]methylidene}-4,5-dihydro-1,3-
oxazol-2-yl)phenyl]-1-diazenyl}-2-naphthyl acetate (4f)
The authors thank Payame Noor University (PNU) of Kerman for
the financial support.
Red powder; mp: 206–208 °C. IR (KBr)
v
:
1797, 1767,
References and notes
1660 cmꢀ1 1H NMR (DMSO-d6, 400 MHz) d: 2.37 (s, 3H), 7.16–
.
1. Song, K. K.; Huang, H.; Han, P.; Zhang, C. L.; Shi, Y.; Chen, Q. X. Biochem. Biophys.
Res. Commun. 2006, 342, 1147.
2. Lee, H. S. J. Agric. Food Chem. 2002, 50, 1400.
3. Masamoto, Y.; Ando, H.; Murata, Y.; Shimoishi, Y.; Tada, M.; Takahata, K. Biosci.
Biotechnol. Biochem. 2003, 67, 631.
8.77 (m, 15H). MS (EI) m/z (%): 42(100), 104(4), 143(26), 171(4),
247(2), 275(6). Anal. Calcd for C29H18N3O5F3: C, 63.85; H, 3.30; N,
12.07. Found: C, 64.06; H, 3.32; N, 11.91.
4. Liu, J. B.; Yi, W.; Wan, Y. Q.; Ma, L.; Song, H. C. Bioorg. Med. Chem. 2008, 14, 1096.
5. Bandgar, P. B.; Adsul, L. K.; Chavan, H. V.; Shringare, S. N.; Korbad, B. L.; Jalde, S.
S.; Lonikar, S. V.; Nile, S. H.; Shirfule, A. L. Bioorg. Med. Chem. 2012, 20, 5649.
6. Cho, J. C.; Rho, H. S.; Joo, Y. H.; Lee, C. S.; Lee, J.; Ahn, S. M.; Kim, J. E.; Shin, S. S.;
Park, Y. H.; Suh, K. D.; Park, S. N. Bioorg. Med. Chem. Lett. 2012, 22, 4159.
7. Ghani, U.; Ullah, N. Bioorg. Med. Chem. 2010, 18, 4042.
8. Yu, C.; Zhou, B.; Su, W.; Xu, Z. Synth. Commun. 2006, 36, 3447.
9. Khan, K. M.; Mughal, U. R.; Khan, M. T. H.; Ullah, Z.; Perveen, S.; Choudhary, M.
I. Bioorg. Med. Chem. 2006, 14, 6027.
10. Tozzini, V.; Bizzarri, A. R.; Pellegrini, V.; Nifosi, R.; Giannozzi, P.; Iuliano, A.
Chem. Phys. 2003, 287, 33.
11. Ozturk, G.; Alp, S.; Timur, S. Dyes Pigments 2008, 76, 792.
12. Catino, S. C.; Farris, R. E. Azo dyes. In Concise Encyclopedia of Chemical
Technology; Grayson, M., Ed.; John Wiley and Sons: New York, 1985; pp 142–
144.
13. Fadda, A. A.; Etmen, H. A.; Amer, F. A.; Barghout, M.; Mohammed, Kh. S. J. Chem.
Technol. Biotechnol. 1994, 61, 343.
14. Manuela, M.; Raposo, M.; Sousa Ana, M. R. C.; Mauricio, A.; Fonseca, C.; Kirsch,
G. Tetrahedron 2005, 61, 8249.
15. Karci, F.; Demircali, A.; Sener, I. Dyes Pigments 2006, 71, 90.
16. Yazdanbakhsh, M. R.; Ghanadzadeh, A.; Moradi, E. J. Mol. Liq. 2007, 136, 165.
17. Cutting, W. C. Handbook of Pharmacology, 3rd ed.; Meredith Company: New
York, 1967.
18. Izatt, R. M.; Christensen, J. H.; Rytting, J. H. Chem. Rev. 1972, 72, 439.
19. Zeng, H.; Lin, Z. P.; Sartorelli, A. C. Biochem. Pharmacol. 2004, 68, 911.
20. Sharma, P.; Rane, N.; Gurram, V. K. Bioorg. Med. Chem. Lett. 2004, 14, 4185.
21. Huang, C. Q.; Wilcoxen, K. M.; Grigoriadis, D. M.; McCarthy, J. R.; Chen, C.
Bioorg. Med. Chem. Lett. 2004, 14, 3943.
3.7. Biology
3.7.1. Tyrosinase inhibition assay
The spectrophotometric assay for tyrosinase was performed
according to the method Ref. 20. Briefly, all the synthesized com-
pounds were screened for the diphenolase inhibitory activity of
tyrosinase using L-DOPA as substrate. All the compounds were dis-
solved in DMSO. The final concentration of DMSO in the test solution
was 2.0%. Phosphate buffer, pH 6.8, was used to dilute the DMSO
stock solution of test compounds. Thirty units of mushroom tyrosi-
nase (0.5 mg/ml) were first pre-incubated with the compounds, in
50 mM phosphate buffer (pH 6.8), for 10 min at 25 °C. Then the L-
DOPA (0.5 mM) was added to the reaction mixture and the enzyme
reaction was monitored by measuring the change in absorbance at
475 nm of formation of the L-DOPA chrome for 10 min. The mea-
surement was performed in triplicate for each concentration and
averaged before further calculation. IC50 value, a concentration giv-
ing 50% inhibition of tyrosinase activity, was determined by interpo-
lation of the dose–response curves. The percent of inhibition of
tyrosinase reaction was calculated as following:
Inhibition ð%Þ ¼ ½B ꢀ S=Bꢂ ꢁ 100
Here, the B and S are the absorbances for the blank and samples.
All the experiments were carried out at least in triplicate and the
results represent means SEM (standard error of the mean). Kojic
22. West, T. P. Microbiol. Res. 2004, 159, 29.
23. Fozooni, S.; Momeni, A.; Hamidian, H.; Khabazzadeh, H. Arkivoc 2008, xiv, 115.
24. Wang, H. M.; Chen, C. Yi.; Chen, C. Y.; Ho, M. L.; Chou, Y. T.; Chang, H. C.; Lee, C.
H.; Wang, C. Z.; Chu, I. M. Bioorg. Med. Chem. 2010, 18, 5241.
25. Han, J.; Ma, I.; Hendzel, M. J.; Turner, J. A. Breast Cancer Res. 2009, 11, R57.